Liver Int
-
Publication Venue For
- The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study.. 41:2467-2473. 2021
- Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury.. 41:2214-2227. 2021
- Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles.. 41:1884-1893. 2021
- Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis.. 41:996-1011. 2021
- Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.. 41:692-704. 2021
- Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation.. 40:830-843. 2020
- Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis.. 39:924-932. 2019
- The influence of drug properties and host factors on delayed onset of symptoms in drug-induced liver injury.. 39:401-410. 2019
- Expanding our toolkit to better identify drug-induced liver injury in electronic medical records.. 38:585-587. 2018
- Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.. 37:1723-1730. 2017
- The diversity and plasticity of adult hepatic progenitor cells and their niche.. 37:1260-1271. 2017
- Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.. 36:1213-1220. 2016
- Liver injury from nonsteroidal anti-inflammatory drugs in the United States.. 36:603-609. 2016
- Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN).. 35:1623-1632. 2015
- Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.. 35:429-437. 2015
- Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.. 34:1018-1024. 2014
- Association of age-dependent liver injury and fibrosis with immune cell populations.. 33:1175-1186. 2013
- Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease.. 33:1062-1070. 2013
- Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis C.. 29:1350-1355. 2009
- Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice.. 29:1262-1272. 2009
- Sustained viral response after interferon-based therapy in chronic hepatitis C: more evidence to support a life-long cure.. 29:481-482. 2009
- Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy.. 28:675-681. 2008